SEATTLE, Sept. 5, 2013 (GLOBE NEWSWIRE) -- Immune Design, a biotech company focused on the development of novel immune-based therapies for cancer and other human diseases, today announced the appointment of Richard T. Kenney, M.D., FACP, as its Chief Medical Officer.
Help employers find you! Check out all the jobs and post your resume.
